These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 8216696)

  • 21. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.
    Yonkers KA; Halbreich U; Freeman E; Brown C; Endicott J; Frank E; Parry B; Pearlstein T; Severino S; Stout A; Stone A; Harrison W
    JAMA; 1997 Sep; 278(12):983-8. PubMed ID: 9307345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolating with physical restraint low status female monkeys during luteal phase might make an appropriate premenstrual depression syndrome model.
    Qiao M; Zhao Q; Zhang H; Wang H; Xue L; Wei S
    J Affect Disord; 2007 Sep; 102(1-3):81-91. PubMed ID: 17258814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressants in the treatment of premenstrual dysphoric disorder.
    Yonkers KA
    J Clin Psychiatry; 1997; 58 Suppl 14():4-10; discussion 11-3. PubMed ID: 9418742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of effect of induced menses on symptoms in women with premenstrual syndrome.
    Schmidt PJ; Nieman LK; Grover GN; Muller KL; Merriam GR; Rubinow DR
    N Engl J Med; 1991 Apr; 324(17):1174-9. PubMed ID: 2011161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria.
    Eriksson E
    Int Clin Psychopharmacol; 1999 May; 14 Suppl 2():S27-33. PubMed ID: 10471170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluvoxamine for premenstrual dysphoric disorder: a pilot study.
    Freeman EW; Rickels K; Sondheimer SJ
    J Clin Psychiatry; 1996; 57 Suppl 8():56-9; discussion 60. PubMed ID: 8698682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria.
    Steinberg S; Annable L; Young SN; Liyanage N
    Biol Psychiatry; 1999 Feb; 45(3):313-20. PubMed ID: 10023508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual depression.
    Brzezinski AA; Wurtman JJ; Wurtman RJ; Gleason R; Greenfield J; Nader T
    Obstet Gynecol; 1990 Aug; 76(2):296-301. PubMed ID: 2371034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of premenstrual use of venlafaxine (flexible dose) in the treatment of premenstrual dysphoric disorder.
    Cohen LS; Soares CN; Lyster A; Cassano P; Brandes M; Leblanc GA
    J Clin Psychopharmacol; 2004 Oct; 24(5):540-3. PubMed ID: 15349012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial.
    Doll H; Brown S; Thurston A; Vessey M
    J R Coll Gen Pract; 1989 Sep; 39(326):364-8. PubMed ID: 2558186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study.
    Wang M; Hammarbäck S; Lindhe BA; Bäckström T
    Acta Obstet Gynecol Scand; 1995 Nov; 74(10):803-8. PubMed ID: 8533564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermittent, luteal phase nefazodone treatment of premenstrual dysphoric disorder.
    Kodesh A; Katz S; Lerner AG; Finkel B; Sigal M
    J Psychopharmacol; 2001 Mar; 15(1):58-60. PubMed ID: 11277610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome.
    Nyberg S; Bäckström T; Zingmark E; Purdy RH; Poromaa IS
    Gynecol Endocrinol; 2007 May; 23(5):257-66. PubMed ID: 17558683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial.
    Cohen LS; Soares CN; Yonkers KA; Bellew KM; Bridges IM; Steiner M
    Psychosom Med; 2004; 66(5):707-13. PubMed ID: 15385695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical management of premenstrual dysphoric disorder.
    Yonkers KA
    J Gend Specif Med; 1999; 2(3):55-60. PubMed ID: 11252853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.
    Jermain DM; Preece CK; Sykes RL; Kuehl TJ; Sulak PJ
    Arch Fam Med; 1999; 8(4):328-32. PubMed ID: 10418540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tryptophan in the treatment of late luteal phase dysphoric disorder: a pilot study.
    Steinberg S; Annable L; Young SN; Bélanger MC
    J Psychiatry Neurosci; 1994 Mar; 19(2):114-9. PubMed ID: 8204563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and treatment of premenstrual dysphoric disorder: an update.
    Steiner M; Born L
    Int Clin Psychopharmacol; 2000 Nov; 15 Suppl 3():S5-17. PubMed ID: 11195269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M; Xiao S
    Am J Psychiatry; 2004 Feb; 161(2):343-51. PubMed ID: 14754784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mood and performance changes in women with premenstrual dysphoric disorder: acute effects of alprazolam.
    Evans SM; Haney M; Levin FR; Foltin RW; Fischman MW
    Neuropsychopharmacology; 1998 Dec; 19(6):499-516. PubMed ID: 9803426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.